All stocks ยท INNOVACAP
IC

INNOVA CAPTAB LIMITED

INNOVACAP BSE Drug Manufacturers - Specialty & Generic Healthcare

Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs and pharmaceutical products in India and internationally. The compaโ€ฆ

ISIN INE0DUT01020
Listed โ€”
Quarters tracked 13
Filings 8 docs

About

Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs and pharmaceutical products in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also offers various generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antiemetic, antidiabetic, antispasmodic, antifibrinolytic, cardiovascular, antioxidant and vitamins, antihyperuricemia and antigout, fluoroquinolone and macrolide, nootropics and neurotonics/neurotrophics, antiulcerative, antimalarial anxiolytic, anticonvulsant and antipsychotic, bladder and prostate disorder, antifungal, anthelmintic and antiviral, anticholinergic, anti-asthmatic, and bronchodilator products in the form of tablets, capsules, dry syrups, dry powder injection, ointments, and liquid orals. The company sells its branded generic products through a network of distributors, stockists, and pharmacies, as well as online channels in various e-commerce pharmacy sites. Innova Captab Limited was incorporated in 2005 and is based in Panchkula, India.

Key Metrics

as of Sep 2026
Market Cap6,733 Cr
P/E43.70
Div Yield0.17 %
Book Valueโ‚น191.00
52w Highโ‚น1,200.00
52w Lowโ‚น608.00
Face Valueโ‚น10.00

Quarterly Results

Rs. Crores ยท hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 400.00 358.00 364.00 290.00 287.00 243.00 249.00 240.00 227.00 198.00 236.00 212.00 219.00
Expenses 346.00 320.00 317.00 260.00 252.00 214.00 216.00 207.00 198.00 175.00 206.00 185.00 191.00
Operating Profit 54.00 39.00 47.00 29.00 35.00 28.00 32.00 33.00 28.00 23.00 31.00 26.00 28.00
OPM % 14.00 11.00 13.00 10.00 12.00 12.00 13.00 14.00 13.00 12.00 13.00 12.00 13.00
Other Income 3.00 3.00 3.00 5.00 4.00 4.00 3.00 4.00 5.00 6.00 2.00 2.00 1.00
Depreciation 10.00 9.00 9.00 9.00 9.00 8.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00
Interest 4.00 4.00 3.00 5.00 3.00 2.00 0.00 0.00 0.00 0.00 4.00 5.00 4.00
Profit before tax 43.00 28.00 37.00 19.00 27.00 23.00 33.00 34.00 30.00 26.00 26.00 20.00 21.00
Tax % 25.00 24.00 25.00 26.00 26.00 25.00 26.00 25.00 25.00 25.00 27.00 29.00 29.00
Net Profit 32.00 21.00 28.00 14.00 20.00 17.00 24.00 26.00 22.00 20.00 19.00 14.00 15.00
EPS in Rs 5.60 3.70 4.88 2.50 3.55 2.99 4.26 4.48 3.90 3.45 3.26 3.01 3.19

Profit & Loss

Annual ยท Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Sales 1,299.00958.00865.00859.00785.00411.00373.00
Expenses 1,147.00836.00755.00760.00687.00356.00322.00
Operating Profit 151.00122.00110.0099.0099.0054.0051.00
OPM % 12.0013.0013.0011.0013.0013.0014.00
Other Income 13.0017.009.009.003.001.001.00
Interest 15.002.0014.0018.005.004.005.00
Depreciation 37.0017.0011.0011.007.006.0010.00
Profit before tax 112.00120.0094.0078.0089.0046.0038.00
Tax % 25.0025.0027.0026.0025.0026.0026.00
Net Profit 84.0089.0068.0058.0066.0034.0028.00
EPS in Rs 14.6215.6311.9111.99551.50287.50232.42
Dividend Payout % 14.000.000.000.000.000.000.00

Balance Sheet

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Equity Capital 57.0057.0057.0048.0012.0012.0012.00
Reserves 829.00756.00666.00220.00199.00133.0098.00
Borrowings 321.00329.00244.00237.00176.0045.0054.00
Other Liabilities 339.00223.00187.00173.00157.00178.0081.00
Total Liabilities 1,547.001,365.001,155.00678.00544.00368.00245.00
Fixed Assets 648.00637.00164.00161.00161.0079.0073.00
CWIP 15.0021.00339.0022.000.007.000.00
Investments 101.0060.0060.0060.0060.000.000.00
Other Assets 782.00647.00593.00435.00322.00282.00172.00
Total Assets 1,547.001,365.001,155.00678.00544.00368.00245.00

Cash Flows

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Cash from Operating Activity 34.0020.00112.0039.0058.0042.0031.00
Cash from Investing Activity -14.00-100.00-472.00-88.00-188.00-20.00-6.00
Cash from Financing Activity -34.0084.00368.0051.00125.00-19.00-23.00
Net Cash Flow -14.004.008.003.00-5.003.001.00
Free Cash Flow -28.00-141.00-165.00-39.00-21.0023.0027.00
CFO/OP % 36.0032.00123.0059.0080.00101.0079.00

Ratios

Annual ยท Days / % โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Debtor Days 93.0095.0092.0098.0081.00123.0085.00
Inventory Days 103.0094.0068.0067.0063.00107.0084.00
Days Payable 145.00119.00111.00102.0084.00132.0092.00
Cash Conversion Cycle 51.0070.0049.0063.0060.0099.0077.00
Working Capital Days 82.0065.0058.0044.0023.0039.0045.00
ROCE % 11.0012.0015.0021.0033.0028.00โ€”

Shareholding Pattern

% holding โ€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023
Promoters 50.90 50.90 50.90 50.90 50.90 50.90 50.90 50.90 50.90 50.90 50.90
FIIs 0.34 0.23 0.10 0.08 0.23 0.35 0.74 1.01 1.19 1.94 3.57
DIIs 19.92 20.14 20.24 20.17 19.67 19.77 19.96 20.61 21.24 20.78 10.31
Public 28.84 28.74 28.76 28.86 29.20 29.00 28.41 27.48 26.67 26.39 35.22
No. of Shareholders 35,881 36,965 38,691 40,245 41,014 39,996 36,692 32,254 35,115 39,396 139,117

Corporate Actions

1 records
ActionEx DateRecord DateRatioAmount (โ‚น)Notes
Dividend 30 Jan 2026 30 Jan 2026 โ€” 2.00

Announcements

5 filings